Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. International Study Group

JG Ayres, ED Bateman, B Lundback, TA Harris
European Respiratory Journal 1995 8: 579-586; DOI:
JG Ayres
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ED Bateman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B Lundback
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TA Harris
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 8 no. 4 579-586
PubMed 
7664857

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Published online April 1, 1995.

Copyright & Usage 
© 1995

Author Information

  1. JG Ayres,
  2. ED Bateman,
  3. B Lundback and
  4. TA Harris

Article usage

Article usage: August 2004 to February 2021

AbstractFullPdf
Aug 2004400
Sep 20041008
Oct 20049017
Nov 20047011
Dec 2004504
Jan 20057012
Feb 20051209
Mar 200511021
Apr 20059012
May 200515011
Jun 20059015
Jul 2005409
Aug 2005902
Sep 2005409
Oct 200515011
Nov 20058011
Dec 2005402
Jan 20069011
Feb 20069010
Mar 20067011
Apr 2006907
May 2006909
Jun 2006402
Jul 2006706
Aug 2006608
Sep 2006708
Oct 2006707
Nov 2006606
Dec 20067012
Jan 2007908
Feb 2007807
Mar 200718013
Apr 200714011
May 20071107
Jun 20071007
Jul 20071308
Aug 2007704
Sep 2007607
Oct 20072409
Nov 20071204
Dec 2007404
Jan 20088012
Feb 200819017
Mar 20081107
Apr 2008907
May 20081107
Jun 200812012
Jul 2008907
Aug 2008309
Sep 200814014
Oct 2008607
Nov 20081308
Dec 20088014
Jan 2009308
Feb 20091306
Mar 200916012
Apr 200921012
May 200912014
Jun 2009803
Jul 20091308
Aug 2009806
Sep 20091508
Oct 20091308
Nov 20098013
Dec 2009804
Jan 2010907
Feb 2010703
Mar 201017012
Apr 201020020
May 20108025
Jun 20102017
Jul 20107010
Aug 201013013
Sep 201027030
Oct 20108021
Nov 201016020
Dec 201017016
Jan 201110023
Feb 201116016
Mar 20118028
Apr 201116018
May 201119023
Jun 201123025
Jul 201118018
Aug 201123014
Sep 20111309
Oct 20119013
Nov 201113014
Dec 201117020
Jan 201222023
Feb 201214013
Mar 20129624
Apr 20128122
May 201212029
Jun 201212014
Jul 201213020
Aug 201212022
Sep 201215017
Oct 201213027
Nov 201215029
Dec 201218023
Jan 201319021
Feb 201311222
Mar 201316017
Apr 201314020
May 20139018
Jun 20134012
Jul 20135010
Aug 20131209
Sep 20133016
Oct 20133010
Nov 20131008
Dec 2013908
Jan 20145220
Feb 201416017
Mar 201423011
Apr 201416016
May 201410013
Jun 20143034
Jul 20143011
Aug 20144123
Sep 20145013
Oct 20141005
Nov 2014415
Dec 20147014
Jan 20155012
Feb 20151103
Mar 201511011
Apr 2015508
May 2015805
Jun 2015509
Jul 201515012
Aug 2015416
Sep 20151108
Oct 201517014
Nov 20155018
Dec 20151204
Jan 201613018
Feb 20161502
Mar 201623015
Apr 201613010
May 201621010
Jun 201619021
Jul 20161309
Aug 201610011
Sep 20166012
Oct 2016708
Nov 20161409
Dec 201613010
Jan 2017908
Feb 20171003
Mar 20171808
Apr 2017902
May 20172808
Jun 20171307
Jul 201723057
Aug 201717018
Sep 20171708
Oct 20171108
Nov 201728010
Dec 20171605
Jan 201813012
Feb 20181405
Mar 20181305
Apr 20181208
May 20181403
Jun 20181500
Jul 20181002
Aug 2018803
Sep 20181106
Oct 20181605
Nov 2018603
Dec 20181302
Jan 2019601
Feb 20191103
Mar 2019908
Apr 2019602
May 2019507
Jun 2019706
Jul 2019806
Aug 2019305
Sep 201915012
Oct 2019701
Nov 20191103
Dec 2019403
Jan 2020706
Feb 20201003
Mar 20201106
Apr 2020707
May 2020604
Jun 2020902
Jul 2020503
Aug 2020300
Sep 20202206
Oct 20201807
Nov 20201507
Dec 20201804
Jan 2021501
Feb 2021802

Altmetrics

PreviousNext
Back to top
Vol 8 Issue 4 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. International Study Group
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. International Study Group
JG Ayres, ED Bateman, B Lundback, TA Harris
European Respiratory Journal Apr 1995, 8 (4) 579-586;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. International Study Group
JG Ayres, ED Bateman, B Lundback, TA Harris
European Respiratory Journal Apr 1995, 8 (4) 579-586;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Lung volume reduction surgery versus conservative treatment in severe emphysema
  • Inhaled isotonic alkaline versus saline solution and radioaerosol clearance in chronic cough
  • Aerosol delivery from spacers in wheezy infants: a daily life study
Show more Clinical Trial

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society